Showing 381 - 400 results of 2,687 for search '"chemotherapy"', query time: 0.05s Refine Results
  1. 381
  2. 382
  3. 383
  4. 384

    Prognostic and Predictive Values of Metabolic Parameters of F-FDG PET/CT in Patients With Non-Small Cell Lung Cancer Treated With Chemotherapy by Xueyan Li MD, Dawei Wang BM, Lijuan Yu MD

    Published 2019-05-01
    “…Univariate and multivariate analyses synergistically showed that late PET/CT stage and MTV50 >4.04 were independent factors of poor survival in patients with NSCLC who received chemotherapy. Conclusions: Several potential prognostic biomarkers of PET/CT imaging have been extracted for predicting survival and selecting patients with NSCLC who are more likely to benefit from chemotherapy. …”
    Get full text
    Article
  5. 385

    Anaplastic Thyroid Cancer: The Addition of Systemic Chemotherapy to Radiotherapy Led to an Observed Improvement in Survival—A Single Centre Experience and Review of the Literature by Natalie M. Lowe, Sean Loughran, Nicholas J. Slevin, Beng K. Yap

    Published 2014-01-01
    “…Multimodality treatment including surgery when feasible remains the best strategy to improve survival and prevent death from asphyxiation in the management of ATC. The addition of chemotherapy to our institutional protocol led to improved survival but prognosis remains very poor.…”
    Get full text
    Article
  6. 386
  7. 387
  8. 388
  9. 389

    Multifunctional drug delivery nanoparticles for combined chemotherapy/chemodynamic/photothermal therapy against colorectal cancer through synergistic cuproptosis/ferroptosis/apoptosis by Xiuzhang Yan, Heshi Liu, Lei Guo, Chang Liu, Shichen Zhang, Xue Wang, Yixin Tang, Rui Zhou, Xin Jiang, Erlei Wang, Shuohui Gao, Caina Xu

    Published 2025-02-01
    “…On the one hand, the DFMTCH NPs exhibited a range of therapeutic capabilities, including chemotherapy, photothermal therapy (PTT), and chemodynamic therapy (CDT), which collectively enhanced the anti-tumor efficacy of chemotherapeutic agents. …”
    Get full text
    Article
  10. 390
  11. 391
  12. 392

    Analysis of Hepatic Artery Infusion (HAI) Chemotherapy Using Randomized Trials of Floxuridine (FUDR) for Colon Cancer Patients with Multiple Liver Metastases by Yuanming Li

    Published 2022-01-01
    “…These findings have important implications for colon cancer adjuvant HAI chemotherapy.…”
    Get full text
    Article
  13. 393
  14. 394
  15. 395
  16. 396

    Genomic characterization and molecular predictive biomarkers for chemotherapy in patients with metastatic triple-negative breast cancer treated in a real-world setting by Erik Olsson, Henrik Lindman, Evangelos Digkas, Viktoria Thurfjell, Haidar Mir Ali, Ute Krüger, Anna-Karin Wennstig, Marie Sundqvist, Antonios Valachis

    Published 2025-02-01
    “…Altered genes and pathways were correlated with overall survival (OS) and evaluated regarding their association with real-world progression-free survival (rwPFS) in patients treated with different chemotherapy agents. Occurrence of alterations were compared between patients with exceptional response and rapid progression to chemotherapy. …”
    Get full text
    Article
  17. 397

    Clinical Outcomes of Ileostomy Closure before Adjuvant Chemotherapy after Rectal Cancer Surgery: An Observational Study from a Chinese Center by Zhen Sun, Yufeng Zhao, Lu Liu, Jichao Qin

    Published 2021-01-01
    “…Patients undergoing ileostomy closure before adjuvant chemotherapy (Group I) were compared to patients undergoing closure during (Group II) and after (Group III) adjuvant chemotherapy. …”
    Get full text
    Article
  18. 398

    Clinical Effect of Apatinib Mesylate Tablets Combined with Paclitaxel Concurrent Radiotherapy and Chemotherapy in the First-Line Treatment of Locally Advanced Nasopharyngeal Carcinoma by Dechao Zhan, Zihong Chen, Donghong Yang, Jiyu Wen, Wanwan Liu

    Published 2022-01-01
    “…From March 2016 to June 2018, 114 patients with locally advanced nasopharyngeal carcinoma who received first-line treatment in our hospital were selected as the patient group, and those who received apatinib combined with paclitaxel concurrent radiotherapy and chemotherapy were selected as the research group (n = 54), while those who received paclitaxel concurrent radiotherapy and chemotherapy were selected as the control group (n = 60). …”
    Get full text
    Article
  19. 399
  20. 400